Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05905016 · ClinicalTrials.gov registry record

Prospective Evaluation of the Clinical Utility of Peroral Endoscopic Myotomy for Gastrointestinal Motility Disorders

A clinical trial of Gastroparesis and Achalasia, sponsored by AdventHealth.

Recruiting
Registry status
600
Enrollment target
1
Study location

NCT05905016 is a study of Gastroparesis and Achalasia that is actively recruiting participants, run by AdventHealth. The registered enrollment target is 600 participants, above the 289-participant average among 44 other Gastroparesis trials with a reported enrollment target (108% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05905016, a study of Gastroparesis and Achalasia, is actively recruiting participants, sponsored by AdventHealth.

RECRUITING
Registry status
600 participants
Enrollment target
1
Study location

Study Summary

This is prospective data recording study. All patients will receive standard medical care and no experimental interventions will be performed.

Study Locations (1)

Florida

  • AdventHealth Orlando - Orlando

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2021-10-01
Est. Completion 2027-04

Sponsor

AdventHealth

95 total trials

What the Registry Record Tells You About NCT05905016

The ClinicalTrials.gov registry entry for NCT05905016 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 289-participant average among 44 other Gastroparesis trials with a reported enrollment target (108% higher). The listed sponsor is AdventHealth, which has 95 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Gastroparesis appearing as the primary indexed condition, and to 0 interventions.

NCT05905016 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT05905016 about?

NCT05905016 is a clinical study titled "Prospective Evaluation of the Clinical Utility of Peroral Endoscopic Myotomy for Gastrointestinal Motility Disorders". This is prospective data recording study. All patients will receive standard medical care and no experimental interventions will be performed.

What is the current status of trial NCT05905016?

This trial is currently recruiting. The enrollment target is 600 participants. The study started on 2021-10-01. Estimated completion is 2027-04.

What conditions does trial NCT05905016 study?

This clinical trial studies the following conditions: Gastroparesis, Achalasia, Zenker Diverticulum, Esophageal Spasm, Diffuse, Swallowing Disorder.

Who is sponsoring clinical trial NCT05905016?

This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05905016 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gastroparesis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.